These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33244208)

  • 1. Comment on "Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis".
    Chu JT
    World J Gastroenterol; 2020 Nov; 26(41):6510-6513. PubMed ID: 33244208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
    World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Freeman ML
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of preventive pancreatic duct stent placement in preventing acute pancreatitis after endoscopic retrograde cholangiopancreatography].
    Zhou QZ; Liu TY; Wei YQ; Dong NN; Guo JF; Li P; Ji M; Niu YL; Wang YJ; Zhang ST
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jul; 56(7):990-993. PubMed ID: 35899354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fan JH; Qian JB; Wang YM; Shi RH; Zhao CJ
    World J Gastroenterol; 2015 Jun; 21(24):7577-83. PubMed ID: 26140006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.
    Takenaka M; Fujita T; Sugiyama D; Masuda A; Shiomi H; Sugimoto M; Sanuki T; Hayakumo T; Azuma T; Kutsumi H
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
    Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems with a prophylactic non-expulsive pancreatic stent.
    Martínez Crespo JJ; Serrano Díaz L; Marín Bernabé CM
    Rev Esp Enferm Dig; 2020 Nov; 112(11):888-889. PubMed ID: 33054294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
    Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for pancreatic stenting after sphincterotomy in patients with difficult cannulation.
    Nakahara K; Okuse C; Suetani K; Michikawa Y; Kobayashi S; Otsubo T; Itoh F
    World J Gastroenterol; 2014 Jul; 20(26):8617-23. PubMed ID: 25024617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.
    Tsuchiya T; Itoi T; Sofuni A; Itokawa F; Kurihara T; Ishii K; Tsuji S; Kawai T; Moriyasu F
    J Hepatobiliary Pancreat Surg; 2007; 14(3):302-7. PubMed ID: 17520207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placement of prophylactic pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a meta-analysis.
    Shi QQ; Ning XY; Zhan LL; Tang GD; Lv XP
    World J Gastroenterol; 2014 Jun; 20(22):7040-8. PubMed ID: 24944500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.
    Das A; Singh P; Sivak MV; Chak A
    Gastrointest Endosc; 2007 Jun; 65(7):960-8. PubMed ID: 17331513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can rectal NSAIDs replace prophylactic pancreatic stent placement for the prevention of post-ERCP pancreatitis?
    Elmunzer BJ; Waljee AK
    Gastroenterology; 2014 Jan; 146(1):313-5; discussion 315. PubMed ID: 24269561
    [No Abstract]   [Full Text] [Related]  

  • 17. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Chahal P; Tarnasky PR; Petersen BT; Topazian MD; Levy MJ; Gostout CJ; Baron TH
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):834-9. PubMed ID: 19447196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate and severe postendoscopic retrograde cholangiopancreatography pancreatitis despite prophylactic pancreatic stent placement: the effect of early prophylactic pancreatic stent dislodgement.
    Moffatt DC; Pradermchai K; Avula H; Sherman S; Fogel EL; Lehman GA
    Can J Gastroenterol; 2011 Apr; 25(4):215-9. PubMed ID: 21523263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography.
    Balmadrid B; Kozarek R
    Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):385-403. PubMed ID: 23540966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pancreatic stent to prevent post-ERCP acute pancreatitis: Is it always "true" prophylaxis?
    Grassia R; Mazza S; Drago A; Verga MC; Soro S; Elvo B; Baiocchi GL
    Gastrointest Endosc; 2022 Jun; 95(6):1271-1272. PubMed ID: 35240117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.